169 related articles for article (PubMed ID: 12714495)
1. Factor V New Brunswick: Ala221Val associated with FV deficiency reproduced in vitro and functionally characterized.
Steen M; Miteva M; Villoutreix BO; Yamazaki T; Dahlbäck B
Blood; 2003 Aug; 102(4):1316-22. PubMed ID: 12714495
[TBL] [Abstract][Full Text] [Related]
2. Functional characterization of a novel missense mutation, His147Arg, in A1 domain of FV protein causing type II deficiency.
Liu HC; Lin TM; Eng HL; Lin YT; Shen MC
Thromb Res; 2014 Jul; 134(1):153-9. PubMed ID: 24787990
[TBL] [Abstract][Full Text] [Related]
3. Importance of individual activated protein C cleavage site regions in coagulation factor V for factor Va inactivation and for factor Xa activation.
Heeb MJ; Rehemtulla A; Moussalli M; Kojima Y; Kaufman RJ
Eur J Biochem; 1999 Feb; 260(1):64-75. PubMed ID: 10091585
[TBL] [Abstract][Full Text] [Related]
4. Arg2074Cys missense mutation in the C2 domain of factor V causing moderately severe factor V deficiency: molecular characterization by expression of the recombinant protein.
Duga S; Montefusco MC; Asselta R; Malcovati M; Peyvandi F; Santagostino E; Mannucci PM; Tenchini ML
Blood; 2003 Jan; 101(1):173-7. PubMed ID: 12393490
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization of factor V-Ile359Thr: a novel mutation associated with thrombosis.
Steen M; Norstrøm EA; Tholander AL; Bolton-Maggs PH; Mumford A; McVey JH; Tuddenham EG; Dahlbäck B
Blood; 2004 May; 103(9):3381-7. PubMed ID: 14695241
[TBL] [Abstract][Full Text] [Related]
6. Cleavage of factor V at Arg 506 by activated protein C and the expression of anticoagulant activity of factor V.
Thorelli E; Kaufman RJ; Dahlbäck B
Blood; 1999 Apr; 93(8):2552-8. PubMed ID: 10194434
[TBL] [Abstract][Full Text] [Related]
7. Amino acid region 1000-1008 of factor V is a dynamic regulator for the emergence of procoagulant activity.
Wiencek JR; Na M; Hirbawi J; Kalafatis M
J Biol Chem; 2013 Dec; 288(52):37026-38. PubMed ID: 24178294
[TBL] [Abstract][Full Text] [Related]
8. The C-terminal region of the factor V B-domain is crucial for the anticoagulant activity of factor V.
Thorelli E; Kaufman RJ; Dahlbäck B
J Biol Chem; 1998 Jun; 273(26):16140-5. PubMed ID: 9632668
[TBL] [Abstract][Full Text] [Related]
9. The activated protein C (APC)-resistant phenotype of APC cleavage site mutants of recombinant factor V in a reconstituted plasma model.
van der Neut Kolfschoten M; Dirven RJ; Tans G; Rosing J; Vos HL; Bertina RM
Blood Coagul Fibrinolysis; 2002 Apr; 13(3):207-15. PubMed ID: 11943934
[TBL] [Abstract][Full Text] [Related]
10. Ser234Leu missense mutation in the A1 domain of factor V causing moderate factor V deficiency in a Chinese family.
Jin PP; Wang XF; Ding QL; Fu QH; Cai XH; Shen LS; Wang HL
Pathology; 2009; 41(6):566-71. PubMed ID: 19900106
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis of quantitative factor V deficiency associated with factor V R2 haplotype.
Yamazaki T; Nicolaes GA; Sørensen KW; Dahlbäck B
Blood; 2002 Oct; 100(7):2515-21. PubMed ID: 12239164
[TBL] [Abstract][Full Text] [Related]
12. The R2-haplotype associated Asp2194Gly mutation in the light chain of human factor V results in lower expression levels of FV, but has no influence on the glycosylation of Asn2181.
van der Neut Kolfschoten M; Dirven RJ; Vos HL; Bertina RM
Thromb Haemost; 2003 Mar; 89(3):429-37. PubMed ID: 12624624
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of activated protein C resistance. Properties of factor V isolated from an individual with homozygosity for the Arg506 to Gln mutation in the factor V gene.
Aparicio C; Dahlbäck B
Biochem J; 1996 Jan; 313 ( Pt 2)(Pt 2):467-72. PubMed ID: 8573079
[TBL] [Abstract][Full Text] [Related]
14. Activated protein C resistance: molecular mechanisms.
Griffin JH; Heeb MJ; Kojima Y; Fernández JA; Kojima K; Hackeng TM; Greengard JS
Thromb Haemost; 1995 Jul; 74(1):444-8. PubMed ID: 8578503
[TBL] [Abstract][Full Text] [Related]
15. Defining the factor Xa-binding site on factor Va by site-directed glycosylation.
Steen M; Villoutreix BO; Norstrøm EA; Yamazaki T; Dahlbäck B
J Biol Chem; 2002 Dec; 277(51):50022-9. PubMed ID: 12384508
[TBL] [Abstract][Full Text] [Related]
16. Molecular basis of coagulation factor V deficiency caused by the R1698W inter-domain mutation.
Calzavarini S; Villoutreix BO; Lunghi B; Livaja R; Bernardi F; Dahlbäck B
Thromb Haemost; 2013 Jul; 110(1):31-8. PubMed ID: 23616041
[TBL] [Abstract][Full Text] [Related]
17. Pseudo-homozygous activated protein C resistance due to coinheritance of heterozygous factor V Leiden mutation and type I factor V deficiency. Variable expression when analyzed by different activated protein C resistance functional assays.
Delahousse B; Iochmann S; Pouplard C; Fimbel B; Charbonnier B; Gruel Y
Blood Coagul Fibrinolysis; 1997 Nov; 8(8):503-9. PubMed ID: 9491268
[TBL] [Abstract][Full Text] [Related]
18. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
Camire RM; Kalafatis M; Tracy PB
Biochemistry; 1998 Aug; 37(34):11896-906. PubMed ID: 9718313
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of recombinant FV Hong Kong and FV Cambridge.
Norstrøm E; Thorelli E; Dahlbäck B
Blood; 2002 Jul; 100(2):524-30. PubMed ID: 12091344
[TBL] [Abstract][Full Text] [Related]
20. Activated protein C resistance: molecular mechanisms based on studies using purified Gln506-factor V.
Heeb MJ; Kojima Y; Greengard JS; Griffin JH
Blood; 1995 Jun; 85(12):3405-11. PubMed ID: 7780127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
